Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (388)
- Scheduling (national classification system) (171)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
770 result(s) found, displaying 101 to 125
-
Corporate reportsFind out how we are managing shortages of medicines and taking action to limit their effects. Read our 2024 report.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 23 August 2024
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #44, ACCS #38 and Joint ACMS-ACCS #36 meetings held in March 2024
-
Corporate reportsDocuments released under the FOI Act in the 2023/24 financial year
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsRead the meeting statement from 27 June 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Corporate reportsThis Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
-
Meeting statementsCommunique from the 6th meeting of the Women’s Health Products Working Group (WHPWG), 27 March 2024.
-
TGA laboratory testing reportsMedicinal cannabis products are permitted to be supplied into Australia under the Special Access Scheme, by authorised prescribers, and/or for use in clinical trials.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement for meeting 47, held on 31 January 2024.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement for meeting 48 held on 1 May 2024.
-
Corporate reportsThis framework outlines our processes to identify and manage risk relating to breast implants.
-
Scheduling decisions (final)This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under section 52D(2) of the Therapeutic Goods Act 1989, and the reasons for the decision.
-
Corporate reportsThis fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Scheduling decisions (final)Read our notice of final decision to amend (or not amend) the current Poisons Standard
-
Corporate reportsFind out about the seasonal influenza vaccines available for the 2024 southern hemisphere season.
-
Meeting statementsRead the meeting statement from 18 April 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Meeting statementsA meeting statement from the Point-of-care Manufacturing of Medical Devices Complex Manufacturing Hubs in Healthcare Facilities Working Group is now available.
-
Meeting statementsA meeting statement from the Medical Devices Allied Health Sector Working Group is now available.
-
Scheduling decisions (final)Final decision on proposed amendments to the Poisons Standard relating to bromoxynil
-
Meeting statementsA meeting statement from the first meeting of the Point-of-care Manufacturing of Medical Devices Steering Committee is now available.
-
Meeting statementsA meeting statement from the Dental Sector Working Group is now available.
-
Scheduling submissionsFind out about the public submissions on interim decisions for scheduling matters referred to the ACMS #43, ACCS #37 and Joint ACMS-ACCS #35 meetings held in November 2023